Prenylflavone derivatives from Broussonetia papyrifera, inhibit the growth of breast cancer cells in vitro and in vivo

Phytochemistry Letters

Volumn 6, Issue 3, 2013, Pages 331-336

  Guo, Fujiang ^a   Feng, Li ^a   Huang, Cheng ^a   Ding, Hongxia ^b   Zhang, Xintian ^c   Wang, Zhaoyi ^c   Li, Yiming ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shenogen Pharma Group   (China)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Broussonetia papyrifera; ER a36; Growth inhibition; Prenylflavone

Indexed keywords

5,7,3',4' TETRAHYDROXY 3 METHOXY 8 GERANYLFLAVONE; 5,7,3',4' TETRAHYDROXY 3 METHOXY 8,5' DIPRENYLFLAVONE; ANTINEOPLASTIC AGENT; BROUSSOCHLACONE; BROUSSOFLAVONOL; BROUSSONETIA PAPYRIFERA PLANT EXTRACT; ESTROGEN RECEPTOR ALPHA; FLAVONE; FLAVONE DERIVATIVE; PAPYRIFLAVONOL; PLANT EXTRACT; PRENYLFLAVONE DERIVATIVE; UNCLASSIFIED DRUG; URALENOL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BARK; BREAST CANCER; BROUSSONETIA PAPYRIFERA; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

BROUSSONETIA PAPYRIFERA;

EID: 84877035888     PISSN: 18743900     EISSN: 18767486     Source Type: Journal    
DOI: 10.1016/j.phytol.2013.03.017     Document Type: Article

References (29)

1. Auja, M., 2009. ER-a36 and resistance to tamoxifen. Nat. Rev. Clin. Oncol. 6, 558.
2. Chen, R.M., Hu, L.H., An, T.Y., Li, J., Shen, Q., 2002. Natural PTP1B inhibitors from Broussonetia papyrifera. Bioorg. Med. Chem. Lett. 12, 3387-3390. (Pubitemid 35292453)
3. Cheng, Z.J., Lin, C.N., Hwang, T.L., Teng, C.M., 2001. Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 61, 939-946.
4. Feng, W., Li, H., Zheng, X., 2008. Researches of constituents of Broussonetia papyrifera. Chin. J. New Drugs 17, 272-278.
5. Guo, Y., Zhang, X., Meng, J., Wang, Z., 2011. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur. J. Pharmacol. 658, 114-122.
6. Kang, L.G., Zhang, X.T., Xie, Y., Tu, Y.P., Wang, D., Liu, Z.M., Wang, Z.Y., 2010. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 24, 709-721.
7. Kang, L.G., Wang, Z.Y., 2010. Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36. J. Cell. Mol. Med. 14, 1485-1493.
8. Kwak, W.J., Moon, T.C., Lin, C.X., Rhyn, H.G., Jung, H., Lee, E., Kwon, D.Y., Son, K.H., Kim, H.P., Kang, S.S., Murakami, M., Kudo, I., Chang, H.W., 2003. Papyriflavonol A from Broussonetia papyrifera inhibits the passive cutaneous anaphylaxis reaction and has a secretory phospholipase A-2 inhibitory activity. Biol. Pharm. Bull. 26, 299-302. (Pubitemid 39663613)
9. Lee, D., Bhat, K.P.L., Fong, H.H.S., Farnsworth, N.R., Pezzuto, J.M., Kinghorn, A.D., 2001. Aromatase inhibitors from Broussonetia papyrifera. J. Nat. Prod. 64, 1286-1293. (Pubitemid 33029208)
10. Lin, C.N., Lu, C.M., Lin, H.C., Fang, S.C., Shieh, B.J., Hsu, M.F., Wang, J.P., Ko, F.N., Teng, C.M., 1996. Novel antiplatelet constituents from formosan Moraceous plants. J. Nat. Prod. 59, 834-838.
11. Matsumoto, J., Fujimoto, T., Takino, C., Saitoh, M., Hano, Y., Fukai, T., Nomura, T., 1985. Components of Broussonetia papyrifera (L.) VENT. I. Structures of two new isoprenylated flavonols and two chalcone derivatives. Chem. Pharm. Bull. 33, 3250-3256. (Pubitemid 16221845)
12. Miceli, V., Cocciadiferro, L., Fregapane, M., Zarcone, M., Montalto, G., Polito, L.M., Agostara, B., Granata, O.M., Carruba, G., 2011. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. OMICS 15, 313-317.
13. Nguyen, P.H., Sharma, G., Dao, T.T., Uddin, M.N., Kang, K.W., Ndinteh, D.T., Mbafor, J.T., Oha, W.K., 2012. New prenylated isoflavonoids as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Erythrina addisoniae. Bioorg. Med. Chem. 20, 6459-6464.
14. Pelekanou, V., Notas, G., Kampa, M., Tsentelierou, E., Radojicic, J., Leclercq, G., Castanas, E., Stathopoulos, E.N., 2012. ERa36, a new variant of the ERa is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Steroids 77, 928-934.
15. Shi, L., Dong, B., Li, Z.W., Lu, Y.W., Ouyang, T., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T., Lin, B.Y., Wang, Z.Y., Xie, Y.T., 2009. Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer. J. Clin. Oncol. 27, 3423-3429.
16. Sohn, H.Y., Son, K.H., Kwon, C.S., Kang, S.S., 2004. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morusm ongolica Schneider, Broussonetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11, 666-672. (Pubitemid 40007752)
17. Takasugi, M., Kumagai, Y., Nagao, S., Masamune, T., Shirata, A., Takahashi, K., 1980. The cooccurrence of flavan and 1,3-diphenylpropane derivatives in wounded paper mulberry. Chem. Lett. 9, 1459-1460.
18. Takasugi, M., Niino, N., Nagao, S., Anetai, M., Masamune, T., Shirata, A., Takahashi, K., 1984. Eight minor phytoalexins from diseased paper mulberry. Chem. Lett. 13, 689-692.
19. Tiong, C.T., Chen, C., Zhang, S.J., Li, J., Soshilov, A., Denison, M.S., Lee, L.S., Tam, V.H., Wong, S.P., Xu, H.E., Yong, E.L., 2012. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERa protein. Carcinogenesis 33, 1089-1097.
20. Tong, J., Zhang, Q., Huang, X., Fu, X., Qi, S., Wang, Y., Hou, Y., Sheng, J., Sun, Q., 2011. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS ONE 6, e16781.
21. Wang, Z.Y., Zhang, X.T., Shen, P., Loggie, B.W., Chang, Y.C., Deuel, T.F., 2005. Identification, cloning, and expression of human estrogen receptor-a36, a novel variant of human estrogen receptor-a66. Biochem. Biophys. Res. Commun. 336, 1023-1027. (Pubitemid 41383424)
22. Wang, Z.Y., Zhang, X.T., Shen, P., Loggie, B.W., Chang, Y.C., Deuel, T.F., 2006. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. 103, 9063-9068. (Pubitemid 43902533)
23. Wang, Z.Y., Zhang, X.T., Kang, L.G., 2011. Breast cancer - carcinogenesis, cell growth and signaling pathways, in: M. Gunduz, E. Gunduz (Eds.), ISBN: 978-953-307-714-7, InTech.
24. Weidle, U.H., Maisel, D.A., Klostermann, S., Schiller, C., Weiss, E.H., 2011. Intracellular proteins displayed on the surface of tumor cells as targets for therapeutic intervention with antibody-related agents. Cancer Genomic. Proteomic. 8, 49-63.
25. Zhang, P., Wang, S., Wu, Y., Chen, R., Yu, D., 2001. Five new diprenylated flavonols from the leaves of Broussonetia kazinoki. J. Nat. Prod. 64, 1206-1209. (Pubitemid 32937893)
26. Zhang, X.T., Kang, L.G., Ding, L., Vranic, S., Gatalica, Z., Wang, Z.Y., 2011. A positive feedback loop of ER-a36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30, 770-780.
27. Zhang, X.T., Ding, L., Kang, L.G., Wang, Z.Y., 2012. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells. PLoS ONE 7, e30174.
28. Zheng, Z., Cheng, K., Chao, J., Wu, J., Wang, M., 2008. Tyrosinase inhibitors from paper mulberry (Broussonetia papyrifera). Food Chem. 106, 529-535. (Pubitemid 47332864)
29. Zou, Y., Ding, L., Coleman, M., Wang, Z.Y., 2009. Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36. FEBS Lett. 583, 1368-1374.